$1.72
-$0.07
(-3.91%)
Quote as of 3:57 PM EST on 02/10/12
Prana Biotechnology Limited (A...
NASDAQ:PRAN
|
$1.72
-$0.07
(-3.91%)
|
|
| Today's Open | $1.74 |
|---|---|
| Previous Close | $1.79 |
| Daily Range | $1.72 - $1.85 |
| 52-Week Range | $1.28 - $4.50 |
| Market Cap | $48.23M |
| P/E Ratio | -12.79 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 120,293 |
| Average Daily Volume | 128,319 |
| Current FY EPS | $0.00 |
PRAN Information
| Description |
|---|
| The Company develops therapeutic drugs designed to treat the underlying causes of degeneration of the brain and the eye as the aging process progresses, initially focusing on Alzheimer's disease. |
| Sector |
| Healthcare |
| Industry |
| Biotechnology |
News & Commentary
Prana Biotechnology Receives FDA Approval to Commence Clinical Trial for Huntington's Disease Drug;
Mid-Day Update: Stocks Modestly Lower as New Home Sales Hit Record Low
Stocks Lower at Mid-Day as Investors Weigh Geopolitical Events, Housing Data
Closing Bell: Growth & Rebuilding Back On Track (BAC, CREE, MU, NFLX, PRAN)
Mid-Day Update: Stocks Near Flat as Investors Pause Following Yesterday's Surge
Stocks Flat to Lower; Investors Consolidate Gains, Watch Events in Japan and Libya
Closing Bell: Bulls Take a Breather (DG, EE, EWJ, NFLX, PRAN, S, T)
China Analyst: 10 Pharma Stocks With Highest Growth Potential
